Jpmorgan Chase & CO Oncology Institute, Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Oncology Institute, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 54 shares of TOI stock, worth $225. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54
Previous 166
67.47%
Holding current value
$225
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding TOI
# of Institutions
81Shares Held
30.1MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.28MShares$17.9 Million0.0% of portfolio
-
Tiff Advisory Services Inc3.63MShares$15.2 Million1.76% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.36MShares$14 Million0.16% of portfolio
-
Balyasny Asset Management LLC Chicago, IL2.52MShares$10.5 Million0.01% of portfolio
-
Josh Arnold Investment Consultant, LLC Edina, MN2.45MShares$10.2 Million4.75% of portfolio
About Oncology Institute, Inc.
- Ticker TOI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 73,495,504
- Market Cap $306M
- Description
- The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical tr...